www.trustedtabs.org

Your reliable supplier of generic medications.

Check yourbonu$
Site search:
Obvious advantage Tell a friend and get discount! Want to give it a try?
Categories list

Generic Sumatriptan - Imitrex

Search by letter:ABCDEFGHIJKLMNOPQRSTUVWXYZ
Imitrex

Generic Imitrex

Sumatriptan 25/50/100mg

Generic Imitrex is used for the treatment of migraine headaches with or without aura (eg, flashing lights, wavy lines, dark spots).
More info »

€ 2.39 Buy now!
Country, language and currency
Social bookmarks:
Testimonials

Well, I must apologize - I thought surely you were scamming me. But, all of a sudden, my mailbox overflows. I received one order on Thursday, 8 June, and then another on Saturday, 10 June. Almost 1 month from our first effort, but the postal service must be the culprits. With this double supply, you are now going to have to send me a couple of women, so the meds don't go to waste. How can we make this right? What would you like me to do? Thanks. I hope only good karma comes to you. - Curt

Our billing is certified by:

Secure shopping certificates


Special Offer!

News

  • Sumatriptan/Naproxen Helpful in Treating Teens' Migraines - Doctors Lounge

    Sumatriptan/Naproxen Helpful in Treating Teens' MigrainesDoctors LoungeTreatment with sumatriptan and naproxen sodium is well tolerated and effective in reducing migraine pain in adolescents, according to a study published online May 14 in Pediatrics.

  • Teen Migraine Sufferers Need Solutions - dailyRx

    Teen Migraine Sufferers Need SolutionsdailyRxResearchers have found that three varying doses of combo drug Treximet (sumatriptan and naproxen sodium) appear to aid teens suffering from migraines.

  • Finally, effective migraine relief for teenagers? - ModernMedicine

    Finally, effective migraine relief for teenagers?ModernMedicineThe combination of sumatriptan and naproxen sodium safely and effectively relieves acute adolescent migraine pain and its associated symptoms compared with placebo, according to the results of a new randomized trial.

  • NuPathe Announces First Quarter 2012 Financial Results and Operational Highlights - MarketWatch (press release)

    NuPathe Announces First Quarter 2012 Financial Results and Operational HighlightsMarketWatch (press release)In January, the USPTO issued a notice of allowance for US Patent application 12/142604 entitled 'Pharmacokinetics of Iontophoretic Sumatriptan Administration.

  • POZEN Announces Licensing Deal with Desitin Arzneimittel GMBH for MT 400 ... - MarketWatch (press release)

    POZEN Announces Licensing Deal with Desitin Arzneimittel GMBH for MT 400 .

bookmark Bookmark this site
Subscribe to the News
Trusted. Rx approved.